TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
Scanbio Ingredients AS
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
596,893
|
764,572
|
530,283 |
| Financial expenses |
178,527
|
170,638
|
78,381 |
| Earnings before taxes |
42,999
|
72,922
|
74,949 |
| Total assets |
587,276
|
461,336
|
379,792 |
| Current assets |
454,134
|
349,264
|
291,071 |
| Current liabilities |
367,894
|
216,085
|
130,794 |
| Equity capital |
215,834
|
242,247
|
248,507 |
| - share capital |
149,880
|
157,802
|
168,133 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
36.8%
|
52.5%
|
65.4% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
7.2%
|
9.5%
|
14.1% |
| Return on assets (ROA) |
37.7%
|
52.8%
|
40.4% |
| Current ratio |
123.4%
|
161.6%
|
222.5% |
| Return on equity (ROE) |
19.9%
|
30.1%
|
30.2% |
| Change turnover |
-129,296
|
266,873
|
90,358 |
| Change turnover % |
-18%
|
54%
|
21% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.